• Cefazedone (Refosporen): In Vitro Workflow

  2026-09-22

  Build a practical Cefazedone susceptibility workflow around broth microdilution, resistance stratification, and solvent-aware controls. The approach connects cefazedone MIC values with PBP biology and pharmacokinetic context while avoiding unsupported extrapolation from veterinary staphylococcal data.

• Cefodizime Research Workflows and Applications

  2026-09-21

  Cefodizime combines broad-spectrum β-lactam activity with a useful research profile for respiratory, urinary, resistance, and host-response models. This practical guide turns its PBP mechanism, β-lactamase stability, and exploratory immunomodulatory effects into reproducible assay workflows and troubleshooting decisions.

• Bay 11-7821 in NF-κB Inflammation Research

  2026-09-21

  Bay 11-7821 (BAY 11-7082) provides a practical way to test how IKK-linked NF-κB signaling shapes cytokine release, adhesion-marker expression, and cell survival. This workflow connects monocyte infection models with apoptosis and cancer assays while emphasizing controls that distinguish pathway inhibition from compound-related toxicity.

• Sodium Dicloxacillin Monohydrate: Assay Logic

  2026-09-20

  Sodium dicloxacillin monohydrate research requires more than selecting an antibiotic concentration. This guide connects MSSA pharmacology, compartment-specific potency, storage, and spectrophotometric assay strategy to improve interpretation and reproducibility.

• Eltanexor (KPT-8602) Workflow for XPO1 Studies

  2026-09-19

  Build robust Eltanexor experiments around XPO1 target engagement, cancer-cell response, and Wnt/β-catenin pathway readouts. This workflow connects hematologic malignancy models with emerging colorectal cancer chemoprevention data while separating validated findings from practical assay recommendations.

• Patient-Derived Gastric Cancer Assembloids

  2026-09-19

  Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids that combine tumor organoids with matched stromal subpopulations, including fibroblastic, mesenchymal, and endothelial cells. The model reproduced tumor-associated gene-expression patterns and revealed that stromal composition can alter drug sensitivity, supporting more physiologically relevant studies of resistance and personalized treatment.

• Linezolid and Translational Antibacterial Design

  2026-09-18

  Linezolid provides a clinically grounded benchmark for inhibition of bacterial protein synthesis, while spirocyclic POM analogue 5c illustrates how phenotypic screening, resistance analysis, and MmpL3-focused chemistry can advance tuberculosis discovery. This article connects both examples through a practical translational framework without confusing assay potency, mechanistic maturity, or clinical relevance.

• HotStart 2X Green qPCR Master Mix in mRNA Vaccine Studies

  2026-09-17

  Translate targeted mRNA nanovaccine experiments into reproducible transcript-level measurements with a hot-start SYBR workflow. This guide connects delivery and immune-activation questions to practical qPCR design, RNA-seq validation, and troubleshooting decisions.

• Protease and Phosphatase Inhibitor Cocktail for hPSC-CMs

  2026-09-17

  Protect phosphorylation states and protein integrity when profiling chamber-specific human stem cell-derived cardiomyocytes. This EDTA-free, 100X formulation supports cleaner western blot, immunoprecipitation, and signaling workflows without introducing metal chelation that can complicate downstream assays.

• Mechanism-Ready Western Blotting in Atherosclerosis

  2026-09-16

  Mechanistic atherosclerosis studies increasingly depend on immunoblot data that can distinguish true pathway regulation from background, reagent drift, and handling variability. This article connects the octanal–Olfr2–calcium–ROS–NHE1 axis with a more controlled secondary-antibody workflow, using Western Secondary Antibody Dilution Buffer as a practical tool for translational protein detection.

• N-Formimidoyl Thienamycin: Comparative Activity

  2026-09-16

  This 1982 study evaluated N-formimidoyl thienamycin (MK0787) across a broad panel of resistant and clinically important bacteria, using broth-dilution susceptibility testing and bactericidal endpoints. Its main contribution was to show that MK0787 combined broad Gram-negative and Gram-positive activity with apparent independence from β-lactamase production, while retaining especially strong activity against Pseudomonas aeruginosa and Acinetobacter spp.

• RGFP966 and the Next Wave of HO-1 Biology

  2026-09-15

  A translational framework for pairing real-time HO-1 activity imaging with RGFP966-based perturbation to separate enzyme abundance, localization, and function in disease-relevant models.

• Erlotinib and SCUBE3: Rethinking EGFR Resistance

  2026-09-15

  Erlotinib (NSC 718781) offers a precise way to interrogate EGFR dependence, while new evidence positions secretory SCUBE3 as a broader driver of oncogenic signaling, therapy resistance, and immune suppression. This thought-leadership article outlines how translational researchers can combine EGFR-focused pharmacology with SCUBE3-aware experimental design without overstating an unproven combination strategy.

• Fra2/LCN2 Links PM2.5 to Asthma Ferroptosis

  2026-09-14

  The reference study identifies a Fra2/LCN2 signaling axis that connects PM2.5 exposure with mitophagy dysfunction, iron accumulation, and ferroptosis in M2 macrophages during asthma exacerbation. Its combination of multi-omics, promoter binding analysis, ultrastructural imaging, and macrophage-specific LCN2 knockdown provides a mechanistic framework for studying environment-associated airway inflammation.

• CLCC1 and Herpesvirus Nuclear Egress Fusion

  2026-09-14

  A genome-wide CRISPR screen in herpes simplex virus 1 identified CLCC1 as a host factor required for the membrane-fusion step of nuclear egress. The findings connect defective viral capsid release with impaired nuclear pore insertion in uninfected cells, supporting an ancient role for CLCC1 in nuclear-envelope morphogenesis.

8141 records 4/543 page Previous Next 12345 下5页 Last page